Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

SICKLE CELL DISEASE ASSOCIATION OF AMERICA

Filed by ARTEMIS POLICY GROUP LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 20, 2026
Income
$20,000.00
Expenses
Not reported
Filing UUID
46665a96-6346-4ee9-b468-7d0a3bdebc94
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Funding for federal sickle cell disease programs FY26 House and Senate Labor-HHS Appropriations bills

MMM · Medicare/Medicaid

Engagement with the Center for Medicare and Medicaid Innovation on the Cell & Gene Therapy Access Model Sickle Cell Disease Comprehensive Care Act (S. 721/H.R. 5178) Medicaid eligibility and coverage for needed services for people living with sickle cell disease H.R. 1, One Big Beautiful Bill Act

Literal federal measure citations: S. 721, H.R. 5178, H.R. 1

HCR · Health Issues

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 (H.R. 1796/S. 735)

Literal federal measure citations: H.R. 1796, S. 735

INS · Insurance

H.R. 1, One Big Beautiful Bill Act Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.

Literal federal measure citations: H.R. 1, HR 247, HR 1, HR 5371, S 46

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.